1-10 of 10
sulfation
Close
Sort by
Journal Articles

Comparison of the Functional Characteristics and Post-Translational Modifications of Commercial Factor VIII Products

Guido Kohla, PhD, Larisa Belyanskaya, PhD, Maya Tiemeyer, PhD, Thole Züchner, PhD, Irena Knappik, PhD, Julia Rosenlöcher, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2362.
https://doi.org/10.1182/blood.V130.Suppl_1.2362.2362
Published: 2017
Journal Articles

Structural and Functional Characterization of a Codon Optimized Coagulation Factor VIII

Svetlana A Shestopal, PhD, James H Kurasawa, MS, Jian-Jiang Hao, PhD, Elena Karnaukhova, PhD, Yideng Liang, PhD, Min Lin, PhD, Mikhail V Ovanesov, PhD, Timothy K Lee, PhD, John H McVey, PhD, Andrey G Sarafanov, PhD
Journal: Blood
Blood (2016) 128 (22): 3765.
https://doi.org/10.1182/blood.V128.22.3765.3765
Published: 2016
Journal Articles

The Pharmacokinetics Of Turoctocog Alfa Are Consistent Over Different Concentrations and Production Lots

Víctor Jiménez-Yuste, PhD, Sandra Lejniece, PhD, MD, Robert Klamroth, MD, PhD, Trine Saugstrup, Judi Moss
Journal: Blood
Blood (2013) 122 (21): 4783.
https://doi.org/10.1182/blood.V122.21.4783.4783
Published: 2013
Journal Articles

Pre-Clinical Characterization and Analysis of Long Lasting Recombinant Factor IXFc

John V Amari, PhD, Qi Lu, PhD, Mark Slein, BS, Robert Peters, PhD
Journal: Blood
Blood (2010) 116 (21): 4415.
https://doi.org/10.1182/blood.V116.21.4415.4415
Published: 2010
Journal Articles

Recombinant Human Coagulation Factor IX Expressed in HEK293 Cells: Influence of Serin Phosphorylation and Tyrosine Sulfation on Pharmacokinetic Properties in FIX-Knock-out Mice

Ernst Boehm, PhD, Michael Dockal, PhD, Meinhard Hasslacher, PhD, Artur Mitterer, PhD, Eva M Muchitsch, PhD, Manfred Reiter, PhD, Friedrich Scheiflinger, PhD
Journal: Blood
Blood (2008) 112 (11): 4098.
https://doi.org/10.1182/blood.V112.11.4098.4098
Published: 2008
Journal Articles

Site-directed mutagenesis of platelet glycoprotein Ibα demonstrating residues involved in the sulfation of tyrosines 276, 278, and 279

A. Sasha Tait, Jing-Fei Dong, José A. López, Ian W. Dawes, Beng H. Chong
Journal: Blood
Blood (2002) 99 (12): 4422–4427.
https://doi.org/10.1182/blood.V99.12.4422
Published: 2002
Journal Articles

The Duffy-binding-like domain 1 of Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1) is a heparan sulfate ligand that requires 12 mers for binding

Antonio Barragan, Victor Fernandez, Qijun Chen, Anne von Euler, Mats Wahlgren, Dorothe Spillmann
Journal: Blood
Blood (2000) 95 (11): 3594–3599.
https://doi.org/10.1182/blood.V95.11.3594
Published: 2000
Journal Articles

Structurally Specific Heparan Sulfates Support Primitive Human Hematopoiesis by Formation of a Multimolecular Stem Cell Niche

Pankaj Gupta, Theodore R. Oegema, Jr, Joseph J. Brazil, Arkadiusz Z. Dudek, Arne Slungaard, Catherine M. Verfaillie
Journal: Blood
Blood (1998) 92 (12): 4641–4651.
https://doi.org/10.1182/blood.V92.12.4641
Published: 1998
Journal Articles

A Novel P-Selectin Glycoprotein Ligand-1 Monoclonal Antibody Recognizes an Epitope Within the Tyrosine Sulfate Motif of Human PSGL-1 and Blocks Recognition of Both P- and L-Selectin

Karen R. Snapp, Han Ding, Kristin Atkins, Roger Warnke, Francis W. Luscinskas, Geoffrey S. Kansas
Journal: Blood
Blood (1998) 91 (1): 154–164.
https://doi.org/10.1182/blood.V91.1.154
Published: 1998
Journal Articles

A Hematopoietic Cell L-Selectin Ligand Exhibits Sulfate-Independent Binding Activity

Robert Sackstein, Ling Fu, Katrina L. Allen
Journal: Blood
Blood (1997) 89 (8): 2773–2781.
https://doi.org/10.1182/blood.V89.8.2773
Published: 1997